Rinvoq ER 15 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FPW4M
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $45,267
Award facts
- Contract value 100% obligated
- $45,266.61 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $45,266.61. This non-competitive, non-set-aside delivery order is scheduled for completion by December 17, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. RINVOQ (upadacitinib) is a targeted synthetic immunosuppressant used primarily in the treatment of rheumatoid arthritis and other inflammatory conditions, reflecting the Defense Logistics Agency Medical Supply Chain's ongoing procurement of specialized pharmaceutical products to support military healthcare systems.
This delivery order represents a task issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. As the prime vendor on this comprehensive global pharmaceutical support vehicle, AmerisourceBergen supplies a broad range of medications and medical commodities to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The company's position as a major pharmaceutical distributor and the repetitive nature of these delivery orders demonstrate its critical role in the federal medical procurement supply chain.
Quick answers
Who was awarded contract SPE2DR26FPW4M?
SPE2DR26FPW4M was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 16, 2025.
How much is contract SPE2DR26FPW4M worth?
The government has obligated $45,267 on SPE2DR26FPW4M.
Is contract SPE2DR26FPW4M an order under another contract?
Yes. SPE2DR26FPW4M is a delivery order under SPE2DR25D1034, an indefinite delivery contract.
Was contract SPE2DR26FPW4M competed?
The extent of competition for SPE2DR26FPW4M was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award